In the fast-paced and highly regulated pharmaceutical industry, the efficient management of labeling and regulatory submissions is crucial for ensuring compliance, patient safety, and the fast and successful market entry of innovative drugs. However, this process comes with its fair share of challenges. From navigating Chemistry, Manufacturing, and Controls (CMC) regulatory requirements to addressing global labeling and clinical labeling use cases, pharmaceutical companies face complex hurdles in meeting regulatory standards while improving their speed to market. This leaves many highly regulated life science organizations to wonder – is it possible to increase speed while increasing compliance?